# Lucid Diagnostics Inc. (LUCD)

Source: https://www.quantisnow.com/company/LUCD
Generated: 2026-11-22T14:42:33.896Z

- Ticker: LUCD
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Medical/Dental Instruments
- IPO year: 2021
- SEC CIK: 0001799011
- Website: luciddx.com

## About

Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. It focuses on patients with gastroesophageal reflux disease, also known as chronic heartburn, acid reflux or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. The company's lead products include EsoGuard, a laboratory developed esophageal DNA test that examines individuals DNA molecules for the presence or absence of cytosine methylation; and EsoCheck, a cell collection device that collects cells of targeted region of the esophagus. Lucid Diagnostics Inc. was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. is a subsidiary of PAVmed Inc.

## Latest LUCD news and filings

- 2026-11-13 13:00 UTC [Earnings] [PAVmed Provides Business Update and Reports Preliminary Third Quarter 2026 Financial Results](https://www.quantisnow.com/insight/pavmed-provides-business-update-and-reports-preliminary-third-quarter-2026-6789453)
- 2026-11-12 13:11 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Lucid Diagnostics Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-lucid-diagnostics-inc-6786557)
- 2026-11-12 13:05 UTC [SEC Form 8-K] [Lucid Diagnostics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/lucid-diagnostics-inc-filed-sec-form-8-k-results-of-operations-6786535)
- 2026-11-12 13:00 UTC [Earnings] [Lucid Diagnostics Provides Business Update and Reports Third Quarter 2026 Financial Results](https://www.quantisnow.com/insight/lucid-diagnostics-provides-business-update-and-reports-third-quarter-2026-6786527)
- 2026-11-05 13:25 UTC [Lucid Diagnostics Recognized as a GenomeWeb Best Place to Work for Second Consecutive Year](https://www.quantisnow.com/insight/lucid-diagnostics-recognized-as-a-genomeweb-best-place-to-work-6774974)
- 2026-11-04 13:55 UTC [Conference Announcement] [Lucid Diagnostics to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum](https://www.quantisnow.com/insight/lucid-diagnostics-to-participate-in-the-canaccord-genuity-medtech-diagnostics-6771617)
- 2026-11-03 13:15 UTC [Lucid Diagnostics Announces Publication of Landmark 12,000-Patient Real-World EsoGuard® Study](https://www.quantisnow.com/insight/lucid-diagnostics-announces-publication-of-landmark-12000-patient-real-world-esoguard-study-6768655)
- 2026-10-30 12:30 UTC [Earnings Date] [PAVmed to Hold Third Quarter 2026 Business Update Conference Call and Webcast on November 13, 2026](https://www.quantisnow.com/insight/pavmed-to-hold-third-quarter-2026-business-update-conference-call-6764685)
- 2026-10-29 12:30 UTC [Earnings Date] [Lucid Diagnostics to Hold Third Quarter 2026 Business Update Conference Call and Webcast on November 12, 2026](https://www.quantisnow.com/insight/lucid-diagnostics-to-hold-third-quarter-2026-business-update-conference-6762799)
- 2026-10-23 15:59 UTC [Oil Above $100 Puts Penny Stocks in Focus](https://www.quantisnow.com/insight/oil-above-100-puts-penny-stocks-in-focus-6756106)
- 2026-10-22 20:34 UTC [SEC Form 8-K] [SEC Form 8-K filed by Lucid Diagnostics Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-lucid-diagnostics-inc-6755397)
- 2026-10-22 20:20 UTC [Dividends] [Lucid Diagnostics Begins Receiving Medicare Reimbursement for EsoGuard® and Closes $15 Million Financing](https://www.quantisnow.com/insight/lucid-diagnostics-begins-receiving-medicare-reimbursement-for-esoguard-and-closes-6755269)
- 2026-10-16 20:30 UTC [SEC Form 8-K] [SEC Form 8-K filed by Lucid Diagnostics Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-lucid-diagnostics-inc-6749299)
- 2026-09-22 13:06 UTC [SEC Form 8-K] [Lucid Diagnostics Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/lucid-diagnostics-inc-filed-sec-form-8-k-regulation-fd-disclosure-6722649)
- 2026-09-22 11:55 UTC [Lucid Diagnostics Advances Multiple EsoGuard® and EsoCheck® Payment, Billing and Coding Pathways](https://www.quantisnow.com/insight/lucid-diagnostics-advances-multiple-esoguard-and-esocheck-payment-billing-and-6722362)
- 2026-08-14 12:00 UTC [Earnings Date] [PAVmed Provides Business Update and Reports Second Quarter 2026 Financial Results](https://www.quantisnow.com/insight/pavmed-provides-business-update-and-reports-second-quarter-2026-financial-6681878)
- 2026-08-13 12:23 UTC [SEC Form 8-K] [Lucid Diagnostics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition](https://www.quantisnow.com/insight/lucid-diagnostics-inc-filed-sec-form-8-k-results-of-operations-6679487)
- 2026-08-13 12:00 UTC [Earnings Date] [Lucid Diagnostics Provides Business Update and Reports Second Quarter 2026 Financial Results](https://www.quantisnow.com/insight/lucid-diagnostics-provides-business-update-and-reports-second-quarter-2026-6679418)
- 2026-08-12 20:30 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Lucid Diagnostics Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-lucid-diagnostics-inc-6678237)
- 2026-08-05 12:46 UTC [Lucid Diagnostics Secures Commercial Coverage Policy Spanning Multiple Health Plans for its EsoGuard® Esophageal DNA Test](https://www.quantisnow.com/insight/lucid-diagnostics-secures-commercial-coverage-policy-spanning-multiple-health-plans-6664265)
- 2026-08-04 12:30 UTC [Conference Announcement] [Lucid Diagnostics to Participate in Upcoming Investor Conferences](https://www.quantisnow.com/insight/lucid-diagnostics-to-participate-in-upcoming-investor-conferences-6661325)
- 2026-07-31 12:30 UTC [Earnings Date] [PAVmed to Hold Second Quarter 2026 Business Update Conference Call and Webcast on August 14, 2026](https://www.quantisnow.com/insight/pavmed-to-hold-second-quarter-2026-business-update-conference-call-6657274)
- 2026-07-30 12:30 UTC [Earnings Date] [Lucid Diagnostics to Hold Second Quarter 2026 Business Update Conference Call and Webcast on August 13, 2026](https://www.quantisnow.com/insight/lucid-diagnostics-to-hold-second-quarter-2026-business-update-conference-6655274)
- 2026-06-24 21:00 UTC [SEC Form 8-K] [Lucid Diagnostics Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders](https://www.quantisnow.com/insight/lucid-diagnostics-inc-filed-sec-form-8-k-submission-of-matters-6614523)
- 2026-05-21 20:20 UTC [Insider Buy] [Director Matheis Dennis bought $245,270 worth of shares (245,000 units at $1.00), increasing direct ownership by 31% to 1,033,443 units (SEC Form 4)](https://www.quantisnow.com/insight/director-matheis-dennis-bought-245270-worth-of-shares-245000-units-6567602)
- 2026-05-15 12:00 UTC [Public Offering] [PAVmed Provides Business Update and Reports First Quarter 2026 Financial Results](https://www.quantisnow.com/insight/pavmed-provides-business-update-and-reports-first-quarter-2026-financial-6555772)
- 2026-05-14 12:05 UTC [SEC Form 8-K] [Lucid Diagnostics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/lucid-diagnostics-inc-filed-sec-form-8-k-results-of-operations-6552572)
- 2026-05-14 12:00 UTC [Public Offering] [Lucid Diagnostics Provides Business Update and Reports First Quarter 2026 Financial Results](https://www.quantisnow.com/insight/lucid-diagnostics-provides-business-update-and-reports-first-quarter-2026-6552524)
- 2026-05-13 20:31 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Lucid Diagnostics Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-lucid-diagnostics-inc-6551302)
- 2026-05-01 12:31 UTC [Earnings Date] [PAVmed to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 15, 2026](https://www.quantisnow.com/insight/pavmed-to-hold-first-quarter-2026-business-update-conference-call-6526026)
- 2026-04-30 21:03 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by Lucid Diagnostics Inc.](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-lucid-diagnostics-inc-6525337)
- 2026-04-30 21:00 UTC [SEC Form DEF 14A] [SEC Form DEF 14A filed by Lucid Diagnostics Inc.](https://www.quantisnow.com/insight/sec-form-def-14a-filed-by-lucid-diagnostics-inc-6525306)
- 2026-04-30 12:31 UTC [Earnings Date] [Lucid Diagnostics to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 14, 2026](https://www.quantisnow.com/insight/lucid-diagnostics-to-hold-first-quarter-2026-business-update-conference-6523158)
- 2026-04-24 21:15 UTC [SEC Form 3] [Amendment: New insider Lee Victoria Tou-Ho claimed ownership of 650,000 shares (SEC Form 3)](https://www.quantisnow.com/insight/amendment-new-insider-lee-victoria-tou-ho-claimed-ownership-of-650000-6514996)
- 2026-04-24 20:30 UTC [SEC Form 8-K] [Lucid Diagnostics Inc. filed SEC Form 8-K: Regulation FD Disclosure](https://www.quantisnow.com/insight/lucid-diagnostics-inc-filed-sec-form-8-k-regulation-fd-disclosure-6514709)
- 2026-04-24 14:23 UTC [Public Offering] [Lucid Diagnostics Announces Closing of $18 Million Underwritten Offering of Common Stock](https://www.quantisnow.com/insight/lucid-diagnostics-announces-closing-of-18-million-underwritten-offering-of-6513899)
- 2026-04-23 21:29 UTC [SEC Form 424B5] [SEC Form 424B5 filed by Lucid Diagnostics Inc.](https://www.quantisnow.com/insight/sec-form-424b5-filed-by-lucid-diagnostics-inc-6513208)
- 2026-04-23 20:30 UTC [SEC Form 8-K] [Lucid Diagnostics Inc. filed SEC Form 8-K: Regulation FD Disclosure](https://www.quantisnow.com/insight/lucid-diagnostics-inc-filed-sec-form-8-k-regulation-fd-disclosure-6512847)
- 2026-04-23 12:30 UTC [Public Offering] [Lucid Diagnostics Announces $18 Million Underwritten Offering of Common Stock](https://www.quantisnow.com/insight/lucid-diagnostics-announces-18-million-underwritten-offering-of-common-stock-6511815)
- 2026-04-20 21:09 UTC [SEC Form PRE 14A] [SEC Form PRE 14A filed by Lucid Diagnostics Inc.](https://www.quantisnow.com/insight/sec-form-pre-14a-filed-by-lucid-diagnostics-inc-6507051)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/LUCD
- Earnings history: https://www.quantisnow.com/earnings/LUCD
- Dividend history: https://www.quantisnow.com/dividends/LUCD
- Insider transactions: https://www.quantisnow.com/insiders/LUCD
- Options chain: https://www.quantisnow.com/options/LUCD
- SEC 8-K filings only: https://www.quantisnow.com/company/LUCD/8-k
- RSS and alerts for LUCD: https://www.quantisnow.com/docs/rss-feeds.md
